News & Updates

Show Multimedia Only

Adjunctive GLP-1 RA treatment of limited benefit in stable IBD patients with obesity, diabetes

01 Jul 2026

In patients with stable inflammatory bowel disease (IBD) receiving advanced therapies who have comorbid obesity and/or diabetes, adjunctive treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide or tirzepatide does not appear to improve clinical outcomes, according to new research.

Adjunctive GLP-1 RA treatment of limited benefit in stable IBD patients with obesity, diabetes

01 Jul 2026

Multi-pronged strategy may boost CRC screening uptake in SG

30 Jun 2026 by

A multi-pronged approach can help improve colorectal cancer (CRC) screening uptake in Singapore, suggests a recent study.

Multi-pronged strategy may boost CRC screening uptake in SG

30 Jun 2026

Dietary inflammatory index not linked to objective disease activity in IBD

29 Jun 2026 by

Significant associations do not exist between inflammatory potential of the diet and objective markers of disease activity in a cohort of patients with inflammatory bowel disease (IBD), according to a study.

Dietary inflammatory index not linked to objective disease activity in IBD

29 Jun 2026

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Treatment with oral glucocorticoids may contribute to elevated risks of adverse psychiatric outcomes, including the onset and relapse of common psychiatric disorders, as shown in a population-based cohort study.

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Paradoxical change in microbiome structure tied to gastric cancer, atrophy

28 Jun 2026

A recent study has found a paradoxical change in the microbiome structure in the development of severe gastric mucosal atrophy, which appears to have a significant association with the progression of gastric atrophy and gastric cancer risk.

Paradoxical change in microbiome structure tied to gastric cancer, atrophy

28 Jun 2026

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

26 Jun 2026

Administration of terlipressin as either continuous or bolus infusion results in similar length of hospital stay, packed cell volume, rebleeding, and mortality rates in patients with acute variceal haemorrhage, a recent study has shown.

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

26 Jun 2026

Novel single-use colonoscope viable, but imaging enhancements needed

23 Jun 2026 by

A novel single-use electronic colonoscope performs similarly as the conventional reusable system in terms of patient comfort, procedural outcomes, and safety, despite the inferior image quality, as shown in an exploratory randomized trial.

Novel single-use colonoscope viable, but imaging enhancements needed

23 Jun 2026

Sugar-sweetened beverages implicated in liver cancer

22 Jun 2026

Consumption of sugar-sweetened beverages may contribute to an increased risk of liver cancer, according to a meta-analysis.

Sugar-sweetened beverages implicated in liver cancer

22 Jun 2026

Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension

21 Jun 2026 by

Treatment with seladelpar for 4 years yields consistent biochemical efficacy, with no new safety concerns, among patients with cirrhosis and primary biliary cholangitis (PBC), as shown by interim results from the open-label ASSURE study.

Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension

21 Jun 2026

VISTAS: Volixibat alleviates cholestatic itch in PSC

16 Jun 2026 by

The investigational ileal bile acid transporter (IBAT) inhibitor volixibat provides rapid and sustained improvement in pruritus in patients with primary sclerosing cholangitis, according to the topline results of the VISTAS study.

VISTAS: Volixibat alleviates cholestatic itch in PSC

16 Jun 2026

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

Adjunctive GLP-1 RA treatment of limited benefit in stable IBD patients with obesity, diabetes

Adjunctive GLP-1 RA treatment of limited benefit in stable IBD patients with obesity, diabetes

Multi-pronged strategy may boost CRC screening uptake in SG

Multi-pronged strategy may boost CRC screening uptake in SG

Dietary inflammatory index not linked to objective disease activity in IBD

Dietary inflammatory index not linked to objective disease activity in IBD

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Paradoxical change in microbiome structure tied to gastric cancer, atrophy

Paradoxical change in microbiome structure tied to gastric cancer, atrophy

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

Novel single-use colonoscope viable, but imaging enhancements needed

Novel single-use colonoscope viable, but imaging enhancements needed

Sugar-sweetened beverages implicated in liver cancer

Sugar-sweetened beverages implicated in liver cancer

Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension

Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension

VISTAS: Volixibat alleviates cholestatic itch in PSC

VISTAS: Volixibat alleviates cholestatic itch in PSC